Point72 Hong Kong’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,325
| Closed | -$62.3K | – | 686 |
|
|
2024
Q1 | $62.3K | Sell |
3,325
-7,609
| -70% | -$143K | ﹤0.01% | 440 |
|
|
2023
Q4 | $237K | Buy |
+10,934
| New | +$237K | 0.01% | 409 |
|
|
2022
Q3 | – | Sell |
-9,927
| Closed | -$321K | – | 1832 |
|
|
2022
Q2 | $321K | Buy |
9,927
+1,176
| +13% | +$38K | 0.01% | 481 |
|
|
2022
Q1 | $290K | Buy |
8,751
+4,521
| +107% | +$150K | 0.01% | 406 |
|
|
2021
Q4 | $180K | Sell |
4,230
-448
| -10% | -$19.1K | 0.01% | 492 |
|
|
2021
Q3 | $207K | Buy |
+4,678
| New | +$207K | 0.01% | 561 |
|
|
2020
Q2 | – | Sell |
-412
| Closed | -$12K | – | 1389 |
|
|
2020
Q1 | $12K | Sell |
412
-988
| -71% | -$28.8K | 0.01% | 647 |
|
|
2019
Q4 | $101K | Buy |
1,400
+350
| +33% | +$25.3K | 0.02% | 504 |
|
|
2019
Q3 | $147K | Buy |
1,050
+808
| +334% | +$113K | 0.04% | 362 |
|
|
2019
Q2 | $44K | Buy |
+242
| New | +$44K | 0.01% | 653 |
|
|
2018
Q4 | – | Sell |
-603
| Closed | -$85K | – | 1159 |
|
|
2018
Q3 | $85K | Buy |
603
+416
| +222% | +$58.6K | 0.03% | 366 |
|
|
2018
Q2 | $29K | Buy |
+187
| New | +$29K | 0.01% | 524 |
|
|
2017
Q4 | – | Sell |
-67
| Closed | -$4K | – | 1058 |
|
|
2017
Q3 | $4K | Buy |
+67
| New | +$4K | ﹤0.01% | 596 |
|
|
2017
Q2 | – | Sell |
-613
| Closed | -$44K | – | 1006 |
|
|
2017
Q1 | $44K | Buy |
613
+606
| +8,657% | +$43.5K | 0.06% | 262 |
|
|
2016
Q4 | $0 | Buy |
+7
| New | – | ﹤0.01% | 1020 |
|